VAFSEO
Akebia Therapeutics, Inc.
Application Filed: 2018-06-07
Trademark Application Details
SECOND EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87952874 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | John L. DuPre' |
| Attorney Docket Number | 5046.0012-00 |
| Law Office Assigned | N80 |
| Employee Name | KLUWE, CHERYL D |
Timeline
| 2018-06-07 | Application Filed |
| 2018-11-27 | Published for Opposition |
| 2019-01-22 | Location: INTENT TO USE SECTION |
| 2019-12-09 | Status: Live/Pending |
| 2019-12-11 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Akebia Therapeutics, Inc. |
| Address | 245 First Street, Suite 1100 Cambridge DE 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia |
| GS0051 | pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-06-11 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-06-14 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-09-25 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2018-09-27 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2018-09-27 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-09-27 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2018-09-27 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-09-28 | 8 CNSA P: |
| ASSIGNED TO LIE | 2018-10-15 | 9 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-11-07 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-11-27 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-11-27 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-01-22 | 13 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-07-02 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-07-02 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-07-02 | 16 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-07-04 | 17 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-12-09 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2019-12-09 | 19 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-12-09 | 20 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-11 | 21 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-06-04 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2020-06-04 | 23 EXT3 S: |
| EXTENSION 3 GRANTED | 2020-06-04 | 24 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-06-06 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-12-21 | 26 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2020-12-21 | 27 EXT4 S: |
| EXTENSION 4 GRANTED | 2020-12-21 | 28 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-23 | 29 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-06-08 | 30 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-06-15 | 31 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2021-06-08 | 32 EXT5 S: |
| EXTENSION 5 GRANTED | 2021-06-15 | 33 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-06-16 | 34 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-01-24 | 35 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2022-01-24 | 36 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-01-25 | 37 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2022-02-24 | 38 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2022-02-24 | 39 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-02-24 | 40 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-08-24 | 41 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-08-24 | 42 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-08-25 | 43 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-09-19 | 44 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-09-20 | 45 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-10-25 | 46 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-10-25 | 47 NRCC E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-04-18 | 48 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-04-18 | 49 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-04-18 | 50 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-04-18 | 51 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-04-18 | 52 CHAN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VAFSEO 97289838 not registered Live/Pending |
Akebia Therapeutics, Inc. 2022-03-01 |
 VAFSEO 87952874 not registered Live/Pending |
Akebia Therapeutics, Inc. 2018-06-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 